Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Feasibility Study to Identify T-cell Responses to Neo-epitopes in Tumor Invaded Lymph Nodes

NCT02831634 is registered in ClinicalTrials.gov with Institut Curie as lead sponsor.

NCT NCT02831634
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02831634 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Feasibility Study to Identify T-cell Responses to Neo-epitopes in Tumor Invaded Lymph Nodes
Lead sponsor
Institut Curie
Phase
Not applicable
Overall status
Completed
Start date
June 9, 2016
Completion date
March 1, 2018
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, cutaneous melanoma